Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model - Top-Institutions - MDSpire

Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model

  • By

  • Mohammad Majd Hammour

  • Lisa Herzberger

  • Yuxuan Xin

  • Guanqiao Chen

  • Melike Tombaz

  • Sabrina Ehnert

  • Fabian Springer

  • Georg Damm

  • Massoud Vosough

  • Jan G. Hengstler

  • Ursula Müller-Vieira

  • Andreas K. Nüssler

  • Romina H. Aspera-Werz

  • May 13, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Metabolism

  • #2

    NewYork-Presbyterian Hospital–Columbia and Cornell
    NewYork-Presbyterian Hospital–Columbia and Cornell

    New York, New York

    Key Differentiators

    • Endocrinology
    • Diabetes

  • #3

    University of Iowa
    University of Iowa

    Iowa City, Iowa

    Key Differentiators

    • Endocrinology

  • #4

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Endocrinology

  • #5

    Endocrine Society
    Endocrine Society

    Washington, D.C.

    Key Differentiators

    • Endocrinology

Original Source(s)

Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model

  • by Mohammad Majd Hammour, Lisa Herzberger, Yuxuan Xin, Guanqiao Chen, Melike Tombaz, Sabrina Ehnert, Fabian Springer, Georg Damm, Massoud Vosough, Jan G. Hengstler, Ursula Müller-Vieira, Andreas K. Nüssler, Romina H. Aspera-Werz

  • May 13, 2026

Related Content

STAT investigates the epidemic killing 178,000 Americans a year

Impaired Iron-Copper Metabolic Axis in Human Intestinal Mucosa After Roux-en-Y Gastric Bypass: A Prospective Transcriptomic Study Using Double-Balloon Enteroscopy

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases